CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Royalty Pharma Fiscal Q3 2019 Earnings Report - CapyFin

Royalty Pharma

RPRX · NASDAQ🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q4 2025 in 4d Q3 2025 +6.82%Q2 2025 -2.11%Q1 2025 +0.92%Q4 2024 +1.67%Q3 2024 -3.70%Q2 2024 -3.63%Q1 2024 +0.36%Q4 2023 +2.12%Q3 2023 -0.51%Q2 2023 -0.88%Q1 2023 -4.67%Q4 2022 -2.00%Q3 2022 +1.56%Q2 2022 -0.93%Q1 2022 -8.06%Q4 2021 +3.55%Q3 2021 +1.49%Q2 2021 +2.66%Q1 2021 -2.19%Q4 2020 -2.15%Q3 2020 -1.61%Q2 2020 -3.05%Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019 Q3 2017 Q2 2017 Q1 2017 Q4 2016 Q3 2016 Q2 2016 Q1 2016 Q4 2015 Q3 2015 Q2 2015 Q1 2015 Q4 2014 Q3 2014 Q2 2014 Q1 2014 Q4 2013 Q3 2013 Q2 2013 Q1 2013 Q4 2012 Q3 2012 Q2 2012

Sep 30, 2019

•

Sep 30, 2019

Royalty Pharma Q3 2019 Earnings Report

Portfolio Receipts

Royalty Pharma

Unlock previous datapoints

Royalty Pharma

Unlock previous datapoints

Revenue by Segment

Cystic Fibrosis Franchise Revenue

Unlock previous datapoints

CapyFin.com

Other Products Revenue

Unlock previous datapoints

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Royalty Pharma

Royalty Pharma Revenue by Segment